Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-035315
Filing Date
2024-11-14
Accepted
2024-11-14 16:16:03
Documents
56
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbla20240930_10q.htm   iXBRL 10-Q 936712
2 EXHIBIT 10.4 ex_745371.htm EX-10.4 45214
3 EXHIBIT 10.5 ex_745372.htm EX-10.5 43877
4 EXHIBIT 10.6 ex_745373.htm EX-10.6 50318
5 EXHIBIT 31.1 ex_745377.htm EX-31.1 12573
6 EXHIBIT 31.2 ex_745376.htm EX-31.2 12576
7 EXHIBIT 32.1 ex_745375.htm EX-32.1 5584
8 EXHIBIT 32.2 ex_745374.htm EX-32.2 6082
  Complete submission text file 0001437749-24-035315.txt   4096816

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA pbla-20240930.xsd EX-101.SCH 35158
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbla-20240930_def.xml EX-101.DEF 264888
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbla-20240930_lab.xml EX-101.LAB 213146
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbla-20240930_pre.xml EX-101.PRE 283372
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbla-20240930_cal.xml EX-101.CAL 25533
59 EXTRACTED XBRL INSTANCE DOCUMENT pbla20240930_10q_htm.xml XML 413137
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

EIN.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39468 | Film No.: 241462578
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)